ATLANTA, GA--(Marketwired - March 24, 2015) - LED Medical Diagnostics, Inc. (the "Company" or "LED Medical") (TSX VENTURE: LMD) (LEDIF) (LME.F), a provider of advanced diagnostic imaging products and software to dentists and oral health specialists, announced that management will hold a virtual roadshow conference call and webcast to provide investors with a detailed background and outline the strategy for growth going forward on Monday, March 30th at 4:30 pm EDT.
Dr. David Gane, CEO of LED Medical Diagnostics and Lamar Roberts, President of LED Dental will host the conference call. To attend the call, please use the information below for either dial-in access or webcast access.
Virtual Roadshow Conference Call & Webcast
Date: Monday March 30, 2015
Time: 4:30 PM to 5:30 PM EDT
US Dial-In: +1-877-407-9039
International Dial-In: +1-201-689-8470
Please dial in at least 10 minutes before the call to ensure timely participation.
A replay of the call will be available until April 30th, 2015. To listen please call 1-877-870-5176 within the United States or 1-858-384-5517 if calling internationally. Please use the replay pin number 13604957 to access the replay.
About LED Medical Diagnostics, Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiary LED Dental, provides dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol LMD, the OTCQX under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME. For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.
Forward Looking Statement
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.